首页> 外文期刊>Qatar Medical Journal >Cefazolin and Coagulation Disorder: A case report and review of literature
【24h】

Cefazolin and Coagulation Disorder: A case report and review of literature

机译:头孢唑林与凝血障碍:一例病例报告并文献复习

获取原文
       

摘要

A 63-year old Yemeni male, known case of endstage renal disease (ESRD), hypertension and diabetes mellitus, underwent craniotomy and endoscopic removal of an intraventricular mass. Peri-operatively he was started on cefazolin, a normal diet and regular hemodialysis without heparin. The international normalising ratio (INR) increased rapidly, reaching 4.2 on day five but responded equally rapidly to parenteral Vitamin K and withdrawal of cefazolin. Cefazolin is an antibiotic commonly used in clinical practice because of its long half-life, narrow spectrum and its ability for dose adjustment in renal failure patients. We review the literature, discuss the risk factors of its use and suggest possible mechanisms causing the prolonged coagulation.
机译:一名63岁的也门男性,已知为终末期肾脏疾病(ESRD),高血压和糖尿病,接受了颅骨切开术和内窥镜切除脑室内肿物。围手术期,他开始使用头孢唑林,正常饮食和不使用肝素的定期血液透析。国际正常化比率(INR)迅速增加,在第五天达到4.2,但对肠胃外维生素K和撤出头孢唑林的反应同样迅速。头孢唑林是一种在临床实践中常用的抗生素,因为它的半衰期长,光谱窄并且可以调节肾衰竭患者的剂量。我们回顾了文献,讨论了其使用的危险因素,并提出了导致长时间凝血的可能机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号